Aksys Reports Third Quarter 2006 Financial Results (SYS-CON Media)
Aksys(R), Ltd. , a pioneer in innovative dialysis systems, today reported financial results for the third quarter ended September 30, 2006. Select highlights of the Company's financial results include the following:

Par Pharmaceutical Announces Agreement With GlaxoSmithKline to Settle Imitrex(R) Injection Patent Litigation (FinanzNachrichten)
WOODCLIFF LAKE, N.J., Nov. 13 /PRNewswire-FirstCall/ -- Par Pharmaceutical ( Nachrichten ) Companies, Inc. today announced that its partner, Spectrum Pharmaceuticals, Inc., has entered into a settlement agreement with GlaxoSmithKline ( Nachrichten / Aktienkurs ) (GSK) that resolves U.S. patent litigation related to GSK's Imitrex(R) Injection, thereby eliminating the inherent uncertainty and costs